We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+30.38%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$179M
AUM Growth
+$25.8M
Cap. Flow
-$11.5M
Cap. Flow %
-6.46%
Top 10 Hldgs %
49.87%
Holding
82
New
15
Increased
17
Reduced
25
Closed
12

Top Buys

Rank Stock Value
1
XNCR icon
Xencor
XNCR
+$3.26M
2
ESPR
Esperion Therapeutics
ESPR
+$1.11M
3
VZ icon
Verizon
VZ
+$984K
4
GLD icon
SPDR Gold Trust
GLD
+$806K
5
TGT icon
Target
TGT
+$571K

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.14M
2
XYZ
Block Inc
XYZ
+$1.05M
3
GDX icon
VanEck Gold Miners ETF
GDX
+$740K
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$639K
5
GM icon
General Motors
GM
+$623K

Sector Composition

Rank Sector Weight
1 Healthcare 37.61%
2 Technology 13.76%
3 Communication Services 9.15%
4 Financials 5.23%
5 Consumer Discretionary 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QQQ icon
1
PUT
Invesco QQQ Trust
QQQ
$453B
$12.4M 6.93%
+50,000
New +$11.2M
GLD icon
2
SPDR Gold Trust
GLD
$131B
$11.7M 6.56%
70,000
+5,000
+8% +$806K
ITCI
3
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$10.9M 6.11%
425,500
-7,000
-2% -$142K
SPY icon
4
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$10.8M 6.04%
35,000
-83,500
-70% -$24.4M
GOOG icon
5
Alphabet (Google) Class C
GOOG
$4.36T
$9.4M 5.26%
133,000
+4,000
+3% +$270K
MU icon
6
Micron Technology
MU
$930B
$8.11M 4.54%
157,500
-5,000
-3% -$236K
REGN icon
7
Regeneron Pharmaceuticals
REGN
$78.5B
$7.73M 4.33%
12,400
+250
+2% +$142K
XNCR icon
8
Xencor
XNCR
$1.5B
$6.17M 3.45%
190,367
+106,367
+127% +$3.26M
INCY icon
9
Incyte
INCY
$24.2B
$6.08M 3.4%
58,500
-1,300
-2% -$125K
ABBV icon
10
AbbVie
ABBV
$443B
$5.81M 3.25%
59,150
-6,000
-9% -$528K
ARGX icon
11
argenx
ARGX
$53.4B
$5.41M 3.03%
24,000
– –
ORCL icon
12
Oracle
ORCL
$374B
$4.7M 2.63%
85,000
– –
ALNY icon
13
Alnylam Pharmaceuticals
ALNY
$27.5B
$4.07M 2.28%
27,500
-1,500
-5% -$202K
BAC icon
14
Bank of America
BAC
$435B
$3.98M 2.23%
167,500
– –
AMD icon
15
Advanced Micro Devices
AMD
$776B
$3.95M 2.21%
75,000
-10,000
-12% -$530K
T icon
16
AT&T
T
$159B
$3.78M 2.11%
165,500
-17,212
-9% -$392K
IAU icon
17
iShares Gold Trust
IAU
$62.9B
$3.4M 1.9%
100,000
– –
C icon
18
Citigroup
C
$222B
$3.32M 1.86%
65,000
-10,000
-13% -$474K
VZ icon
19
Verizon
VZ
$195B
$3.17M 1.77%
57,500
+17,500
+44% +$984K
FMS icon
20
Fresenius Medical Care
FMS
$13.8B
$2.88M 1.61%
66,500
– –
AMGN icon
21
Amgen
AMGN
$208B
$2.77M 1.55%
11,750
-1,500
-11% -$342K
ESPR
22
DELISTED
Esperion Therapeutics
ESPR
$2.49M 1.39%
48,500
+26,500
+120% +$1.11M
GDX icon
23
VanEck Gold Miners ETF
GDX
$22.7B
$2.48M 1.39%
67,500
-22,500
-25% -$740K
SGEN
24
DELISTED
Seagen Inc. Common Stock
SGEN
$2.38M 1.33%
14,000
-3,000
-18% -$448K
BMY icon
25
Bristol-Myers Squibb
BMY
$133B
$2.35M 1.32%
40,000
-19,000
-32% -$1.14M
1
2 3 4

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q2 2020 Portfolio in Review

As of Q2 2020, DCF Advisers held 82 positions worth $179M, up 17% from $153M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

DCF Advisers withdrew a net $11.5M in Q2 2020, closing 12 positions and reducing 25 holdings. Its most notable exit was Block Inc, an estimated $1.05M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 31% a quarter earlier, followed by Technology and Communication Services.

Against the trend, DCF Advisers opened a new position in Target worth $600K.

  • DCF Advisers's largest Q2 2020 buy was Target: 5,000 shares worth $600K.
  • DCF Advisers added most to Xencor in Q2 2020, an estimated $3.26M increase.
  • DCF Advisers's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.14M.
  • DCF Advisers fully exited Block Inc in Q2 2020, selling an estimated $1.05M.
  • DCF Advisers's ten largest holdings make up 50% of its $179M portfolio in Q2 2020.
  • DCF Advisers opened 15 new positions and closed 12 in Q2 2020.
  • DCF Advisers's portfolio value rose 17% quarter-over-quarter to $179M.

Based on DCF Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.